Kirstie Baker

550 total citations
5 papers, 188 citations indexed

About

Kirstie Baker is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kirstie Baker has authored 5 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Ophthalmology, 3 papers in Molecular Biology and 1 paper in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kirstie Baker's work include Retinal Diseases and Treatments (5 papers), Retinal and Optic Conditions (2 papers) and Ocular Diseases and Behçet’s Syndrome (2 papers). Kirstie Baker is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Retinal and Optic Conditions (2 papers) and Ocular Diseases and Behçet’s Syndrome (2 papers). Kirstie Baker collaborates with scholars based in United States, India and Brazil. Kirstie Baker's co-authors include Srinivas R. Sadda, Kenneth M. Marion, Xiwen Huang, Wenying Fan, Siva Balasubramanian, Nizar Saleh Abdelfattah, Elizabeth Morgenthien, Akihito Uji, Marco Nassisi and Jianqin Lei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Kirstie Baker

5 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirstie Baker United States	4	141	110	54	13	12	5	188
Raj N. Devasahayam Australia	8	261 1.9×	293 2.7×	37 0.7×	12 0.9×	8 0.7×	10	344
Meenakshi Ambati United States	4	29 0.2×	11 0.1×	43 0.8×	16 1.2×	12 1.0×	4	80
Shuichiro Hirahara Japan	4	117 0.8×	80 0.7×	23 0.4×	6 0.5×		10	136
Yoko Takatsuna Japan	11	305 2.2×	222 2.0×	62 1.1×	9 0.7×		29	347
Hugh Lin United Kingdom	6	194 1.4×	171 1.6×	43 0.8×	13 1.0×		11	218
Maziar Lalezary United States	9	357 2.5×	239 2.2×	68 1.3×	13 1.0×		15	398
Allison C. Umfress United States	8	197 1.4×	76 0.7×	152 2.8×	17 1.3×		14	309
Paolo Turchetti Italy	9	266 1.9×	214 1.9×	34 0.6×	7 0.5×		23	343
А. А. Тихомиров United States	4	96 0.7×	48 0.4×	61 1.1×	5 0.4×	1 0.1×	4	188
Soon Cheol South Korea	8	179 1.3×	91 0.8×	30 0.6×	5 0.4×		26	207

Countries citing papers authored by Kirstie Baker

Since Specialization

Citations

This map shows the geographic impact of Kirstie Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirstie Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirstie Baker more than expected).

Fields of papers citing papers by Kirstie Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirstie Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirstie Baker. The network helps show where Kirstie Baker may publish in the future.

Co-authorship network of co-authors of Kirstie Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Kirstie Baker. A scholar is included among the top collaborators of Kirstie Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirstie Baker. Kirstie Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ambati, Meenakshi, Ivana Apicella, Shao-Bin Wang, et al.. (2021). Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration. Proceedings of the National Academy of Sciences. 118(41). 46 indexed citations

2.

Verma, Aditya, Muneeswar Gupta Nittala, Kirstie Baker, et al.. (2021). Relationship between Preserved Ellipsoid Zone Area and Choroidal Vascularity Index in Autosomal Dominant Retinitis Pigmentosa. Journal of Clinical & Experimental Ophthalmology. 1–6. 2 indexed citations

3.

Narendran, Siddharth, Felipe Pereira, Praveen Yerramothu, et al.. (2021). Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration. Signal Transduction and Targeted Therapy. 6(1). 149–149. 18 indexed citations

4.

Narendran, Siddharth, Felipe Pereira, Praveen Yerramothu, et al.. (2020). A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration. Investigative Ophthalmology & Visual Science. 61(10). 4–4. 10 indexed citations

5.

Nassisi, Marco, Jianqin Lei, Nizar Saleh Abdelfattah, et al.. (2019). OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study. Ophthalmology. 126(12). 1667–1674. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact